GLIMEPIRIDE Side Effects

6492588-4 | Acute Respiratory Distress Syndrome, Condition Aggravated, Diabetes Mellitus, Dialysis, Disseminated Intravascular Coagulation, Gas Gangrene, Multi-organ Failure, Septic Shock
on Dec 09, 2009 Male patient from JAPAN , 60 years of age, weighting 177.3 lb, was diagnosed with type 2 diabetes mellitus, hypertension and was treated with Glimepiride (View Usage). Patient experienced the following unwanted or unexpected effects: acute respiratory distress syndrome, condition aggravated, diabetes mellitus, dialysis (What is dialysis?), disseminated intravascular coagulation, gas gangrene, multi-organ failure, septic shock. Glimepiride dosage: . During the same period patient was treated with ARTIST (View Artist Review and Artist Label ), ADALAT CC (View Adalat Cc Review and Adalat Cc Label ), LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (Dose As Used: 1 Tablet) (View Losartan Potassium And Hydrochlorothiazide Review and Losartan Potassium And Hydrochlorothiazide Label ). Patient was hospitalized.

6482712-1 | Condition Aggravated, Muscular Weakness
Patient was taking Glimepiride (View Usage). Patient had the following side effects: condition aggravated, muscular weakness on Dec 04, 2009 from FRANCE Additional patient health information: Male patient , 73 years of age, was diagnosed with bipolar disorder (What is bipolar disorder?) and. Glimepiride dosage: Dose Unit: 1 Mg. During the same period patient was treated with DEPAKOTE (Dose Unit: 500 Mg) (View Depakote Review and Depakote Label ), CRESTOR (View Crestor Review and Crestor Label ).

6480793-2 | Hypoaesthesia
Adverse event was reported on Nov 23, 2009 by a Male patient taking Glimepiride (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus and. Location: UNITED KINGDOM , 49 years of age, After Glimepiride was administered, patient had the following side effects: hypoaesthesia. During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), PIOGLITAZONE (View Pioglitazone Review and Pioglitazone Label ). Patient was hospitalized.

6427120-4 | Chest Pain, Facial Paresis, Head Discomfort, Paraesthesia, Product Counterfeit, Product Quality Issue
on Oct 26, 2009 Female patient from BRAZIL , weighting 169.8 lb, was diagnosed with diabetes mellitus, hypertension, angioplasty (What is angioplasty?), acute myocardial infarction and was treated with Glimepiride (View Usage). Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), facial paresis, head discomfort, paraesthesia, product counterfeit, product quality issue. Glimepiride dosage: . During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ), PLAVIX (View Plavix Review and Plavix Label ).


6378589-5 | Bladder Cancer
on Sep 22, 2009 Male patient from FINLAND , 60 years of age, was diagnosed with diabetes mellitus and was treated with Glimepiride (View Usage). Patient had the following side effects: bladder cancer (What is bladder cancer?). Glimepiride dosage: . During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), ZOCOR (View Zocor Review and Zocor Label ), NITROSID (View Nitrosid Review and Nitrosid Label ), COZAAR (View Cozaar Review and Cozaar Label ), EMCONCOR /00802601/ (View Emconcor /00802601/ Review and Emconcor /00802601/ Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ). Patient was hospitalized.

6339664-4 | Bladder Cancer
Patient was taking Glimepiride (View Usage). After Glimepiride was administered, patient had the following side effects: bladder cancer (What is bladder cancer?) on Aug 28, 2009 from FINLAND Additional patient health information: Male patient , 60 years of age, was diagnosed with diabetes mellitus and. Glimepiride dosage: . During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), ZOCOR (View Zocor Review and Zocor Label ), NITROSID (View Nitrosid Review and Nitrosid Label ), COZAAR (View Cozaar Review and Cozaar Label ), EMCONCOR /00802601/ (View Emconcor /00802601/ Review and Emconcor /00802601/ Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ). Patient was hospitalized.

6335162-2 | Blood Glucose Decreased, Diabetes Mellitus Inadequate Control, Product Substitution Issue, Weight Increased
Adverse event was reported on Aug 28, 2009 by a Female patient taking Glimepiride (View Usage) (Dosage: 2 Mg Daily) was diagnosed with diabetes mellitus and. Location: UNITED STATES , weighting 165.0 lb, Patient experienced the following unwanted or unexpected effects: blood glucose decreased, diabetes mellitus inadequate control, product substitution issue, weight increased.

6327490-1 | Chest Pain, Facial Paresis, Head Discomfort, Paraesthesia, Product Counterfeit
on Aug 17, 2009 Female patient from BRAZIL , weighting 169.8 lb, was diagnosed with diabetes mellitus, hypertension, angioplasty (What is angioplasty?), acute myocardial infarction and was treated with Glimepiride (View Usage). Patient had the following side effects: chest pain (What is chest pain?), facial paresis, head discomfort, paraesthesia, product counterfeit. Glimepiride dosage: . During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ), PLAVIX (View Plavix Review and Plavix Label ).

6279250-8 | Haematochezia
on Jul 17, 2009 Male patient from UNITED STATES , 51 years of age, weighting 215.0 lb, was diagnosed with blood glucose increased and was treated with Glimepiride (View Usage). After Glimepiride was administered, patient had the following side effects: haematochezia. Glimepiride dosage: 1 Tablet Per Serving Of Food Twice A Day.

6274348-2 | Hypotension, Lactic Acidosis, Renal Failure Acute
Patient was taking Glimepiride (View Usage). Patient experienced the following unwanted or unexpected effects: hypotension, lactic acidosis, renal failure acute on Jul 09, 2009 from NORWAY Additional patient health information: Female patient , 81 years of age, was diagnosed with diabetes mellitus, type 2 diabetes mellitus and. Glimepiride dosage: (4 Mg/day), Oral. During the same period patient was treated with METFORMIN (3 G/day, Oral) (View Metformin Review and Metformin Label ), CALCIUM CHANNEL BLOCKERS (View Calcium Channel Blockers Review and Calcium Channel Blockers Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ).

6273520-5 | Lactic Acidosis, Renal Failure Acute
Adverse event was reported on Jul 09, 2009 by a Female patient taking Glimepiride (View Usage) (Dosage: Glimepiride (4mg/day)) was diagnosed with diabetes mellitus, type 2 diabetes mellitus and. Location: NORWAY , 81 years of age, Patient had the following side effects: lactic acidosis, renal failure acute. During the same period patient was treated with METFORMIN HCL (Metformin (3 G/day)) (View Metformin Hcl Review and Metformin Hcl Label ), CALCIUM CHANNEL BLOCKERS (View Calcium Channel Blockers Review and Calcium Channel Blockers Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ).

6257386-5 | Chest Discomfort, Chest Pain, Dyspepsia, Insomnia, Product Substitution Issue
on Jul 01, 2009 Male patient from UNITED STATES , 82 years of age, weighting 199.0 lb, was diagnosed with diabetes mellitus and was treated with Glimepiride (View Usage). After Glimepiride was administered, patient had the following side effects: chest discomfort, chest pain (What is chest pain?), dyspepsia, insomnia, product substitution issue. Glimepiride dosage: 2mg Twice Daily Other.

6170236-0 | Pemphigoid
on Apr 20, 2009 Female patient from GREECE , 75 years of age, was treated with Glimepiride (View Usage). Patient experienced the following unwanted or unexpected effects: pemphigoid. Glimepiride dosage: . During the same period patient was treated with IRBESARTAN (View Irbesartan Review and Irbesartan Label ), BROMAZEPAM (View Bromazepam Review and Bromazepam Label ).

6158488-4 | Blood Glucose Decreased, Loss Of Consciousness
Patient was taking Glimepiride (View Usage). Patient had the following side effects: blood glucose decreased, loss of consciousness on Apr 14, 2009 from UNITED STATES Additional patient health information: Female patient , 85 years of age, was diagnosed with diabetes mellitus and. Glimepiride dosage: 1 Mg/qd/orally. Patient was hospitalized.

6146835-9 | Blood Glucose Abnormal, Product Quality Issue
Adverse event was reported on Apr 06, 2009 by a Male patient taking Glimepiride (View Usage) (Dosage: 2 Mg Twice A Day) was diagnosed with blood glucose and. Location: UNITED STATES , weighting 275.0 lb, After Glimepiride was administered, patient had the following side effects: blood glucose abnormal, product quality issue.

6146066-2 | Blood Glucose Decreased, Unresponsive To Stimuli
on Apr 02, 2009 Female patient from UNITED STATES , 85 years of age, was diagnosed with diabetes mellitus and was treated with Glimepiride (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose decreased, unresponsive to stimuli. Glimepiride dosage: 1 Mg/qd/orally. Patient was hospitalized.

6126636-8 | Arrhythmia, Dizziness, Hypertension, Nausea
on Mar 09, 2009 Male patient from , 64 years of age, weighting 211.6 lb, was diagnosed with hypertension, dental operation and was treated with Glimepiride (View Usage). Patient had the following side effects: arrhythmia (What is arrhythmia?), dizziness (What is dizziness?), hypertension, nausea (What is nausea?). Glimepiride dosage: . During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), RAMIPRIL (Dose: 2,5) (View Ramipril Review and Ramipril Label ), ARTICAIN (Dose: Not Reported) (View Articain Review and Articain Label ), EPINEPHRINE (Dose: Not Reported) (View Epinephrine Review and Epinephrine Label ). Patient was hospitalized.

6125277-6 | Cardiac Failure, Chest Discomfort, Renal Failure
Patient was taking Glimepiride (View Usage). After Glimepiride was administered, patient had the following side effects: cardiac failure, chest discomfort, renal failure on Mar 19, 2009 from SWEDEN Additional patient health information: Male patient , 61 years of age, weighting 304.7 lb, was diagnosed with type 2 diabetes mellitus and. Glimepiride dosage: Titrated Dose Between 1 Mg And 6 Mg - Oral. During the same period patient was treated with BENDROFLUMETHIAZIDE (View Bendroflumethiazide Review and Bendroflumethiazide Label ), METFORMIN (View Metformin Review and Metformin Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ). Patient was hospitalized.

6122118-8 | Chest Discomfort, Renal Failure
Adverse event was reported on Mar 13, 2009 by a Male patient taking Glimepiride (View Usage) (Dosage: Titrated Dose Between 1 Mg And 6 Mg - Oral) was diagnosed with overweight, type 2 diabetes mellitus and. Location: SWEDEN , 61 years of age, weighting 304.7 lb, Patient experienced the following unwanted or unexpected effects: chest discomfort, renal failure. During the same period patient was treated with METFORMIN (View Metformin Review and Metformin Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ). Patient was hospitalized.

6122117-6 | Cold Sweat, Essential Hypertension, Nausea, Nystagmus, Vision Blurred
on Mar 13, 2009 Male patient from SWEDEN , 67 years of age, weighting 229.7 lb, was diagnosed with diabetes mellitus, overweight and was treated with Glimepiride (View Usage). Patient had the following side effects: cold sweat, essential hypertension, nausea (What is nausea?), nystagmus, vision blurred. Glimepiride dosage: Titrated Dose Between 1 Mg And 6 Mg - Oral. During the same period patient was treated with METFORMIN (View Metformin Review and Metformin Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), ENALAPRIL (View Enalapril Review and Enalapril Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ). Patient was hospitalized.

6121202-2 | Cardiac Failure, Chest Discomfort, Renal Failure
on Mar 09, 2009 Male patient from SWEDEN , 61 years of age, weighting 304.7 lb, was diagnosed with diabetes mellitus inadequate control, hypertension, cardiovascular event prophylaxis and was treated with Glimepiride (View Usage). After Glimepiride was administered, patient had the following side effects: cardiac failure, chest discomfort, renal failure. Glimepiride dosage: Dose: Glimepiride Titrated Dose Between 1 Mg And 6 Mg. During the same period patient was treated with SALURES (View Salures Review and Salures Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), LASIX LONG (View Lasix Long Review and Lasix Long Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), TROMBYL (View Trombyl Review and Trombyl Label ), SPIRONOLAKTON (View Spironolakton Review and Spironolakton Label ). Patient was hospitalized.

6114535-7 | Chest Discomfort
Patient was taking Glimepiride (View Usage). Patient experienced the following unwanted or unexpected effects: chest discomfort on Mar 06, 2009 from SWEDEN Additional patient health information: Male patient , 61 years of age, weighting 304.7 lb, was diagnosed with hypertension and. Glimepiride dosage: Dose: Glimepiride Titrated Dose Between 1 Mg And 6 Mg. During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), LASIX LONG (View Lasix Long Review and Lasix Long Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), TROMBYL (View Trombyl Review and Trombyl Label ), SPIRONOLAKTON (View Spironolakton Review and Spironolakton Label ), SALURES (View Salures Review and Salures Label ). Patient was hospitalized.

6114534-5 | Cold Sweat, Glycosylated Haemoglobin Increased, Hypertension, Nausea, Nystagmus
Adverse event was reported on Mar 06, 2009 by a Male patient taking Glimepiride (View Usage) (Dosage: Dose: Titrated Dose Between 1 Mg And 6 Mg) was diagnosed with overweight, type 2 diabetes mellitus, dyslipidaemia, hypertension, cardiovascular event prophylaxis and. Location: SWEDEN , 67 years of age, weighting 229.7 lb, Patient had the following side effects: cold sweat, glycosylated haemoglobin increased, hypertension, nausea (What is nausea?), nystagmus. During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), ENALAPRIL (View Enalapril Review and Enalapril Label ), SELOKEN /00376902/ (View Seloken /00376902/ Review and Seloken /00376902/ Label ), TROMBYL (View Trombyl Review and Trombyl Label ), IMPUGAN (View Impugan Review and Impugan Label ). Patient was hospitalized.

6073785-9 | Chest Discomfort
on Feb 09, 2009 Male patient from SWEDEN , 61 years of age, weighting 304.7 lb, was diagnosed with type 2 diabetes mellitus and was treated with Glimepiride (View Usage). After Glimepiride was administered, patient had the following side effects: chest discomfort. Glimepiride dosage: Titrated Dose Between 1 Mg And 6 Mg Oral. During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), BENDROFLUMETHIAZIDE (View Bendroflumethiazide Review and Bendroflumethiazide Label ). Patient was hospitalized.

6068214-5 | Chest Discomfort
on Jan 20, 2009 Male patient from SWEDEN , 61 years of age, weighting 304.7 lb, was diagnosed with diabetes mellitus inadequate control, hypertension, cardiovascular event prophylaxis and was treated with Glimepiride (View Usage). Patient experienced the following unwanted or unexpected effects: chest discomfort. Glimepiride dosage: Dose: Glimepiride Titrated Dose Between 1 Mg And 6 Mg. During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), LASIX LONG (View Lasix Long Review and Lasix Long Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), TROMBYL (View Trombyl Review and Trombyl Label ), SPIRONOLAKTON (View Spironolakton Review and Spironolakton Label ), SALURES (View Salures Review and Salures Label ). Patient was hospitalized.

6058107-1 | Completed Suicide
Patient was taking Glimepiride (View Usage). Patient had the following side effects: completed suicide on Jan 16, 2009 from UNITED STATES Additional patient health information: Male patient , 38 years of age, was diagnosed with completed suicide and. Glimepiride dosage: . During the same period patient was treated with TIZANIDINE HCL (View Tizanidine Hcl Review and Tizanidine Hcl Label ).

6054678-X | Heart Rate Increased, Hypoglycaemia
Adverse event was reported on Jan 19, 2009 by a Female patient taking Glimepiride (View Usage) (Dosage: 0.5 Mg, Qd) was diagnosed with type 2 diabetes mellitus, atrial fibrillation (What is atrial fibrillation?) and. Location: JAPAN , 62 years of age, weighting 97.00 lb, After Glimepiride was administered, patient had the following side effects: heart rate increased, hypoglycaemia. During the same period patient was treated with DISOPYRAMIDE (300 Mg, Qd) (View Disopyramide Review and Disopyramide Label ).

6052598-8 | Hypoglycaemia
on Jan 16, 2009 Female patient from JAPAN , 62 years of age, was diagnosed with type 2 diabetes mellitus, atrial fibrillation (What is atrial fibrillation?) and was treated with Glimepiride (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemia. Glimepiride dosage: 0.5 Mg, Qd. During the same period patient was treated with DISOPYRAMIDE (300 Mg, Qd) (View Disopyramide Review and Disopyramide Label ).

6042035-1 | Shock Hypoglycaemic
on Jan 12, 2009 Female patient from GERMANY , 78 years of age, weighting 119.0 lb, was diagnosed with type 2 diabetes mellitus, aortic arteriosclerosis, restless legs syndrome, hypertension, metastatic renal cell carcinoma, depression (What is depression?) and was treated with Glimepiride (View Usage). Patient had the following side effects: shock hypoglycaemic. Glimepiride dosage: . During the same period patient was treated with ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), BLOPRESS PLUS (View Blopress Plus Review and Blopress Plus Label ), IBUPROFEN (1 Df Dosage Form) (View Ibuprofen Review and Ibuprofen Label ), MOLSIDOMINE (1 Df Dosage Form In Day) (View Molsidomine Review and Molsidomine Label ), MADOPAR (100 Mg Levodopa And 25 Mg Benserazide) (View Madopar Review and Madopar Label ), SERTRALINE (View Sertraline Review and Sertraline Label ), VALORON N (View Valoron N Review and Valoron N Label ). Patient was hospitalized.

6026205-4 | Asthenia, Bradycardia, Hypoglycaemic Coma, Palpitations, Vertigo
Patient was taking Glimepiride (View Usage). After Glimepiride was administered, patient had the following side effects: asthenia, bradycardia, hypoglycaemic coma, palpitations, vertigo on Dec 15, 2008 from FRANCE Additional patient health information: Female patient , 59 years of age, . Glimepiride dosage: 1 Mg; 3 Times A Day; Oral. During the same period patient was treated with AVLOCARDYL (PROPRANOLOL) (40 MG) (5 Df; As Needed; Oral) (View Avlocardyl (propranolol) (40 Mg) Review and Avlocardyl (propranolol) (40 Mg) Label ), ISOCARD /00586302/ (ISOSORBIDE DINITRATE) (View Isocard /00586302/ (isosorbide Dinitrate) Review and Isocard /00586302/ (isosorbide Dinitrate) Label ), ALPRAZOLAM MERCK (View Alprazolam Merck Review and Alprazolam Merck Label ), FLECAINE (View Flecaine Review and Flecaine Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), VALSARTAN (View Valsartan Review and Valsartan Label ), XANAX (View Xanax Review and Xanax Label ), SEROPLEX (View Seroplex Review and Seroplex Label ). Patient was hospitalized.

6024120-3 | Alkalosis, Asthma, Lymphocyte Stimulation Test Positive
Adverse event was reported on Dec 09, 2008 by a Female patient taking Glimepiride (View Usage) (Dosage: 1 Mg;daily) was diagnosed with type 2 diabetes mellitus and. Location: JAPAN , 40 years of age, Patient experienced the following unwanted or unexpected effects: alkalosis, asthma (What is asthma?), lymphocyte stimulation test positive. During the same period patient was treated with PIOGLITAZONE HCL (View Pioglitazone Hcl Review and Pioglitazone Hcl Label ), BUFORMIN (BUFORMIN) (View Buformin (buformin) Review and Buformin (buformin) Label ). Patient was hospitalized.

6024115-X | Accidental Poisoning, Asthenia, Bradycardia, Chills, Cold Sweat, Hypertension, Hypoglycaemic Coma, Hypothermia, Palpitations
on Dec 15, 2008 Female patient from FRANCE , 59 years of age, was treated with Glimepiride (View Usage). Patient had the following side effects: accidental poisoning, asthenia, bradycardia, chills, cold sweat, hypertension, hypoglycaemic coma, hypothermia (What is hypothermia?), palpitations. Glimepiride dosage: 1 Mg;tablet;oral;3 Times A Day. During the same period patient was treated with PROPRANOLOL (5 Df;oral) (View Propranolol Review and Propranolol Label ), ISOCARD /00586302/ (ISOSORBIDE MONONITRATE) (View Isocard /00586302/ (isosorbide Mononitrate) Review and Isocard /00586302/ (isosorbide Mononitrate) Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), FLECAINIDE ACETATE (View Flecainide Acetate Review and Flecainide Acetate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), VALSARTAN (View Valsartan Review and Valsartan Label ), XANAX (View Xanax Review and Xanax Label ), SEROPLEX (ESCITALOPRAM OXALATE) (View Seroplex (escitalopram Oxalate) Review and Seroplex (escitalopram Oxalate) Label ). Patient was hospitalized.

6023137-2 | Alkalosis, Asthma, Stridor, Therapeutic Response Decreased
on Dec 09, 2008 Female patient from JAPAN , 40 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Glimepiride (View Usage). After Glimepiride was administered, patient had the following side effects: alkalosis, asthma (What is asthma?), stridor, therapeutic response decreased. Glimepiride dosage: 1 Mg; Daily;. During the same period patient was treated with PIOGLITAZONE (View Pioglitazone Review and Pioglitazone Label ), BUFORMIN (View Buformin Review and Buformin Label ). Patient was hospitalized.

6020799-0 | Anaemia, Pancreatitis Acute, Pancreatitis Chronic
Patient was taking Glimepiride (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, pancreatitis acute, pancreatitis chronic on Dec 15, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 223.5 lb, was diagnosed with type 2 diabetes mellitus, pancreatitis chronic, irritable bowel syndrome (What is irritable bowel syndrome?), hypertension and. Glimepiride dosage: Daily Dose: 4 Milligram(s). During the same period patient was treated with PANCRELIPASE DELAYED RELEASE CAPSULES (Daily Dose: 4 Capsules (one Capsule Per Meal/snack)) (View Pancrelipase Delayed Release Capsules Review and Pancrelipase Delayed Release Capsules Label ), AVANDAMET (Daily Dose: 2 Dosage Form) (View Avandamet Review and Avandamet Label ), RUN IN PHASE (View Run In Phase Review and Run In Phase Label ), DICYCLOMINE HCL (Daily Dose: 40 Milligram(s)) (View Dicyclomine Hcl Review and Dicyclomine Hcl Label ), PROMETHAZINE (View Promethazine Review and Promethazine Label ), BENICAR (Daily Dose: 20 Milligram(s)) (View Benicar Review and Benicar Label ). Patient was hospitalized.

5990332-8 | Anaemia, Pancreatitis Chronic
Adverse event was reported on Dec 01, 2008 by a Female patient taking Glimepiride (View Usage) (Dosage: Daily Dose: 4 Milligram(s)) was diagnosed with type 2 diabetes mellitus, pancreatitis chronic, irritable bowel syndrome (What is irritable bowel syndrome?), hypertension and. Location: UNITED STATES , weighting 223.5 lb, Patient had the following side effects: anaemia, pancreatitis chronic. During the same period patient was treated with PANCRELIPASE DELAYED RELEASE CAPSULES (Daily Dose: 4 Capsules (one Capsule Per Meal/snack)) (View Pancrelipase Delayed Release Capsules Review and Pancrelipase Delayed Release Capsules Label ), RUN IN PHASE (View Run In Phase Review and Run In Phase Label ), AVANDAMET (Daily Dose: 2 Dosage Form) (View Avandamet Review and Avandamet Label ), DICYCLOMINE HCL (Daily Dose: 40 Milligram(s)) (View Dicyclomine Hcl Review and Dicyclomine Hcl Label ), PROMETHAZINE (View Promethazine Review and Promethazine Label ), BENICAR (Daily Dose: 20 Milligram(s)) (View Benicar Review and Benicar Label ). Patient was hospitalized.

5985880-0 | Asthma
on Dec 01, 2008 Female patient from JAPAN , 40 years of age, was diagnosed with type 2 diabetes mellitus, hyperglycaemia and was treated with Glimepiride (View Usage). After Glimepiride was administered, patient had the following side effects: asthma (What is asthma?). Glimepiride dosage: 1 Mg, Qd. During the same period patient was treated with PIOGLITAZONE (View Pioglitazone Review and Pioglitazone Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ), GLICLAZIDE (View Gliclazide Review and Gliclazide Label ), INSULIN (View Insulin Review and Insulin Label ), BUFORMIN (View Buformin Review and Buformin Label ). Patient was hospitalized.

5983332-5 | Bacteraemia, Gastrointestinal Haemorrhage, Hypoglycaemia, Multiple Myeloma, Troponin Increased
on Nov 24, 2008 Male patient from UNITED STATES , 65 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Glimepiride (View Usage). Patient experienced the following unwanted or unexpected effects: bacteraemia, gastrointestinal haemorrhage, hypoglycaemia, multiple myeloma (What is multiple myeloma?), troponin increased. Glimepiride dosage: . During the same period patient was treated with LENALIDOMIDE (View Lenalidomide Review and Lenalidomide Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), TYLENOL (CAPLET) (View Tylenol (caplet) Review and Tylenol (caplet) Label ), AREDIA /00729902/ (View Aredia /00729902/ Review and Aredia /00729902/ Label ), TRICOR /00090101/ (Dose Quantity: 1) (View Tricor /00090101/ Review and Tricor /00090101/ Label ), OXYCONTIN (Dose Quantity: 1) (View Oxycontin Review and Oxycontin Label ), DIFLUCAN (Dose Quantity: 1) (View Diflucan Review and Diflucan Label ). Patient was hospitalized.

5971790-1 | Chest Discomfort
Patient was taking Glimepiride (View Usage). Patient had the following side effects: chest discomfort on Nov 18, 2008 from SWEDEN Additional patient health information: Male patient , 61 years of age, weighting 304.7 lb, was diagnosed with diabetes mellitus inadequate control, hypertension, cardiovascular event prophylaxis and. Glimepiride dosage: Dose: Glimepiride Titrated Dose Between 1 Mg And 6 Mg. During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), LASIX LONG (View Lasix Long Review and Lasix Long Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), TROMBYL (View Trombyl Review and Trombyl Label ), SPIRONOLAKTON (View Spironolakton Review and Spironolakton Label ), SALURES (View Salures Review and Salures Label ). Patient was hospitalized.

5960075-5 | Blood Glucose Decreased, Eating Disorder, Facial Palsy, Flushing, Hypoaesthesia, Paraesthesia, Renal Failure Acute, Unresponsive To Stimuli
Adverse event was reported on Nov 19, 2008 by a Female patient taking Glimepiride (View Usage) (Dosage: 4 Mg Po Qd) was diagnosed with type 2 diabetes mellitus and. Location: UNITED STATES , 74 years of age, weighting 154.3 lb, After Glimepiride was administered, patient had the following side effects: blood glucose decreased, eating disorder (What is eating disorder?), facial palsy, flushing, hypoaesthesia, paraesthesia, renal failure acute, unresponsive to stimuli. During the same period patient was treated with METFORMIN HCL (500 Mg Po Bid) (View Metformin Hcl Review and Metformin Hcl Label ), COLACE (View Colace Review and Colace Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ), MORPHINE (View Morphine Review and Morphine Label ), SENNA (View Senna Review and Senna Label ), ZOFRAN (View Zofran Review and Zofran Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ). Patient was hospitalized.

5959706-5 | Blood Glucose Decreased, Blood Glucose Increased, Convulsion, Incorrect Dose Administered, Mental Status Changes
on Nov 19, 2008 Male patient from UNITED STATES , 51 years of age, weighting 205.0 lb, was diagnosed with diabetes mellitus and was treated with Glimepiride (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose decreased, blood glucose increased, convulsion, incorrect dose administered, mental status changes. Glimepiride dosage: 2mg Po Qd. During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), SENNA (View Senna Review and Senna Label ), MORPHINE (View Morphine Review and Morphine Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ), SSI (View Ssi Review and Ssi Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), COLACE (View Colace Review and Colace Label ).

5926298-6 | Accidental Exposure, Hypoglycaemic Coma
on Oct 02, 2008 Female patient from , 59 years of age, was treated with Glimepiride (View Usage). Patient had the following side effects: accidental exposure, hypoglycaemic coma. Glimepiride dosage: . During the same period patient was treated with ALPRAZOLAM MERCK (View Alprazolam Merck Review and Alprazolam Merck Label ). Patient was hospitalized.

5922252-9 | Basal Cell Carcinoma, Skin Ulcer
Patient was taking Glimepiride (View Usage). After Glimepiride was administered, patient had the following side effects: basal cell carcinoma, skin ulcer on Oct 10, 2008 from ITALY Additional patient health information: Male patient , 66 years of age, weighting 189.6 lb, was diagnosed with type 2 diabetes mellitus and. Glimepiride dosage: . During the same period patient was treated with METFORAL (View Metforal Review and Metforal Label ), TRIATEC PLUS (View Triatec Plus Review and Triatec Plus Label ).

5922251-7 | Prostate Cancer, Prostatic Specific Antigen Increased
Adverse event was reported on Oct 10, 2008 by a Male patient taking Glimepiride (View Usage) (Dosage: ) . Location: SPAIN , 57 years of age, weighting 245.8 lb, Patient experienced the following unwanted or unexpected effects: prostate cancer (What is prostate cancer?), prostatic specific antigen increased. During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), PRITOR PLUS (View Pritor Plus Review and Pritor Plus Label ), CARDURA (View Cardura Review and Cardura Label ), ZARATOR /01326101/ (View Zarator /01326101/ Review and Zarator /01326101/ Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), NORVASC (View Norvasc Review and Norvasc Label ).

5922250-5 | Blood Creatine Phosphokinase Bb Increased
on Oct 10, 2008 Female patient from SPAIN , 64 years of age, weighting 163.8 lb, was diagnosed with type 2 diabetes mellitus, hypertension and was treated with Glimepiride (View Usage). Patient had the following side effects: blood creatine phosphokinase bb increased. Glimepiride dosage: . During the same period patient was treated with DESLORATADINE (View Desloratadine Review and Desloratadine Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ).

5922249-9 | Concomitant Disease Progression, Interstitial Lung Disease
on Oct 10, 2008 Male patient from CANADA , 53 years of age, weighting 250.0 lb, was treated with Glimepiride (View Usage). After Glimepiride was administered, patient had the following side effects: concomitant disease progression, interstitial lung disease. Glimepiride dosage: . Patient was hospitalized.

5922248-7 | Blood Immunoglobulin G Increased, Hepatic Enzyme Increased, Hepatotoxicity, Nausea
Patient was taking Glimepiride (View Usage). Patient experienced the following unwanted or unexpected effects: blood immunoglobulin g increased, hepatic enzyme increased, hepatotoxicity, nausea (What is nausea?) on Oct 10, 2008 from CANADA Additional patient health information: Male patient , 60 years of age, weighting 173.3 lb, . Glimepiride dosage: Dose: Unk. During the same period patient was treated with ALTACE (View Altace Review and Altace Label ), SYMBICORT (View Symbicort Review and Symbicort Label ), METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ), ZOVIRAX (View Zovirax Review and Zovirax Label ).

5921088-2 | Cellulitis, Disease Progression, Eczema Nummular, Gait Disturbance, Oedema Peripheral, Pain In Extremity, Pruritus, Stasis Dermatitis
Adverse event was reported on Oct 10, 2008 by a Female patient taking Glimepiride (View Usage) (Dosage: ) . Location: PERU , 59 years of age, weighting 211.6 lb, Patient had the following side effects: cellulitis (What is cellulitis?), disease progression, eczema nummular, gait disturbance, oedema peripheral, pain in extremity, pruritus, stasis dermatitis. During the same period patient was treated with METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ). Patient was hospitalized.

5921087-0 | Abdominal Pain Upper, Dyspnoea, Gastritis, Nausea, Non-cardiac Chest Pain
on Oct 10, 2008 Female patient from CANADA , 62 years of age, weighting 177.5 lb, was treated with Glimepiride (View Usage). After Glimepiride was administered, patient had the following side effects: abdominal pain upper, dyspnoea, gastritis, nausea (What is nausea?), non-cardiac chest pain. Glimepiride dosage: . During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CALCIUM (View Calcium Review and Calcium Label ), MAGNESIUM SULFATE (View Magnesium Sulfate Review and Magnesium Sulfate Label ), VIT D (View Vit D Review and Vit D Label ). Patient was hospitalized.

5921086-9 | Abdominal Pain, Blood Amylase Increased, Cholecystectomy, Cholelithiasis, Lipase Increased, Pancreatitis Acute
on Oct 10, 2008 Male patient from ITALY , 55 years of age, weighting 216.1 lb, was diagnosed with type 2 diabetes mellitus and was treated with Glimepiride (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), blood amylase increased, cholecystectomy, cholelithiasis, lipase increased, pancreatitis acute. Glimepiride dosage: Dose: Unk. During the same period patient was treated with METFORMIN (Dose: Unk) (View Metformin Review and Metformin Label ), IRBESARTAN (Dose: Unk) (View Irbesartan Review and Irbesartan Label ), SIMVASTATIN (Dose: Unk) (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

5921085-7 | Asthenia, Dermatitis Allergic, Pancreatitis Chronic, Pruritus, Rash
Patient was taking Glimepiride (View Usage). Patient had the following side effects: asthenia, dermatitis allergic, pancreatitis chronic, pruritus, rash (What is rash?) on Oct 10, 2008 from UKRAINE Additional patient health information: Female patient , 72 years of age, weighting 165.3 lb, was diagnosed with type 2 diabetes mellitus and. Glimepiride dosage: . During the same period patient was treated with AMLONG A /01687901/ (View Amlong-a /01687901/ Review and Amlong-a /01687901/ Label ). Patient was hospitalized and became disabled.